Telzuit Medical Technologies Announces Schedule for STATPATCH Advertising Campaign on CNN, MSNBC, Fox News and CNBC

Telzuit Medical Technologies Announces Schedule for STATPATCH Advertising Campaign on CNN, MSNBC, Fox News and CNBC

ORLANDO, Fla., June 6 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. (BULLETIN BOARD: TZMT) announced today that it has posted on its Web site a detailed schedule of the current advertising campaign for its flagship STATPATCH. The Company expects to launch a physician/medical community targeted campaign later this year to coincide with the launch of its STATPATCH Wireless Heart Monitor.

For the schedule go to: http://www.telzuit.com/assets/html/list060506.html

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The company is in the final stages of launching its first product, the STATPATCH wireless heart monitor. The STATPATCH is a full 12-lead, completely wireless Holter monitor, which is new to the marketplace. In conjunction with its strategic partners, Telzuit is also building its own dedicated intranet platform to handle several of the products it will be releasing, including the STATPATCH. Telzuit is based in Orlando, Florida. For more information on Telzuit, its business model and its products, please visit the company's Web site: http://www.telzuit.com/.

Forward-Looking Statement: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact:
James Tolan
Co-Founder, Telzuit Medical Technologies, Inc.
407-354-1222

Brainerd Communicators, Inc.
Jennifer Gery (media)
Todd St.Onge (investors)
212-986-6667

Source: Telzuit Medical Technologies, Inc.

CONTACT: James Tolan, Co-Founder of Telzuit Medical Technologies, Inc.,
+1-407-354-1222; or Media - Jennifer Gery or Investors - Todd St.Onge, both of
Brainerd Communicators, Inc., +1-212-986-6667

Web site: http://www.telzuit.com/

-------
Profile: intent